Lori M. Henderson - May 6, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: General Counsel and Secretary
Signature: /s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol: MRNA
Transactions as of: May 6, 2021
Transactions value $: -$837,474
Form type: 4
Date filed: 5/7/2021, 04:09 PM
Next filing: May 13, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise	$138K	+6.6K	+732.52%	$20.93^*	7.5K	May 6, 2021	Direct	F1
transaction	MRNA	Common Stock	Sale	-$976K	-6.6K	-87.99%	$147.82	901	May 6, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Stock Option (Right to Buy)	Options Exercise	$0	-6.6K	-6.59%	$0.00	93.5K	May 6, 2021	Common Stock	6.6K	$20.93	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
F2	25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.